STOCKHOLM, SWEDEN / ACCESS Newswire / January 5, 2026 / Hilbert Group AB (Nasdaq:HILB B)(FRA:999) ("Hilbert Group" or "the Company"), a leading investment firm focused on bridging traditional and digital assets, today confirmed that the Company’s Chief Investment Officer and principal, Russell Thompson, has acquired additional B-shares in Hilbert Group for a total consideration of […]

Private family investment from Westgate Resorts CEO Jim Gissy sets up Pier for growth The family now owns two of the six wooden piers that exist in Florida today Significant investments in infrastructure, retail and restaurant offerings to come DAYTONA BEACH, Fla., Jan. 05, 2026 (GLOBE NEWSWIRE) — The future of one of Daytona Beach's

(NASDAQ:PCSA), Interim safety and efficacy data to be reported in Q1 VERO BEACH, Fla., Jan. 05, 2026 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage biopharmaceutical company developing Next Generation Cancer (NGC) therapies, today reported that it completed the enrollment and dosing of the 20 patients required for the planned formal interim analysis

(NASDAQ:PBM), NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs, today announced a significant scientific and manufacturing achievement. Through its investment in PsyLabs, Psyence BioMed has become the first Nasdaq-listed company to

(NASDAQ:MYNZ), Initiation of eAArly DETECT 2 – U.S. Clinical Study to Evaluate Performance of Next Generation Test on Advanced Adenomas over Large Patient Population in Preparation for ReconAAsense U.S. FDA Pivotal Trial Results from Feasibility Study of Biomarker Panel in Pancreatic Cancer ProjectStudy Demonstrated a Sensitivity of 100% and Specificity of 95% BERKELEY, Calif. and

Mainz Biomed Provides Review of 2025 Highlights GlobeNewswire January 05, 2026 Initiation of eAArly DETECT 2 – U.S. Clinical Study to Evaluate Performance of Next Generation Test on Advanced Adenomas over Large Patient Population in Preparation for ReconAAsense U.S. FDA Pivotal Trial Results from Feasibility Study of Biomarker Panel in Pancreatic Cancer ProjectStudy Demonstrated a

Gissy Family Investments Purchases the Iconic Sunglow Pier in Daytona Beach GlobeNewswire January 05, 2026 Private family investment from Westgate Resorts CEO Jim Gissy sets up Pier for growth The family now owns two of the six wooden piers that exist in Florida today Significant investments in infrastructure, retail and restaurant offerings to come DAYTONA

Processa Pharmaceuticals Completes Enrollment of 20th Patient for Formal Interim Analysis in Phase 2 NGC-Cap Breast Cancer Study GlobeNewswire January 05, 2026 Interim safety and efficacy data to be reported in Q1 VERO BEACH, Fla., Jan. 05, 2026 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage biopharmaceutical company developing Next Generation Cancer (NGC)

Psyence BioMed Achieves Milestone in Natural Ibogaine HCl Production and Strengthens Balance Sheet With No Debt and $12m Cash GlobeNewswire January 05, 2026 NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs,

MISSION, Kan., Jan. 05, 2026 (GLOBE NEWSWIRE) — (Family Features) Coming inside from a cold day calls for moments spent under a blanket, around a warm fire and curled up with a hot bowl of delicious, comforting food. From chili to pasta, your winter menu is sure to feature filling dishes that warm you and